Firas Zahr, MD
Cardiovascular Disease · Portland, ORNPI 1568637049
Payments from drug & device makers
Across 1,655 payments — averaging $4674.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$6M
- Medtronic$1M
- Philips North America LLC$492K
- GE HealthCare$58K
- Abbott$40K
- Jenavalve Technology, Inc.$39K
- plus $59K from 8 others
Across 20 payments — averaging $3448.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$69K
What the payments were for
- Consulting fees$342,63542%
- Speaking & faculty fees$137,78917%
- Grants$2,9300%
- Travel & lodging$286,56335%
- Food & beverage$40,5325%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 786 | $6,031,464 |
| Medtronic(2 entities) | 699 | $1,016,736 |
| Philips North America LLC | 30 | $491,997 |
| GE HealthCare | 12 | $58,025 |
| Abbott | 48 | $39,635 |
| Jenavalve Technology, Inc. | 12 | $39,077 |
| Abiomed | 2 | $22,100 |
| Biosense Webster, Inc. | 18 | $21,225 |
| Siemens Medical Solutions USA, Inc. | 25 | $10,696 |
| Ancora Heart, Inc. | 5 | $2,463 |
| Boston Scientific | 14 | $1,869 |
| Penumbra, Inc. | 1 | $235 |
| Shockwave Medical, Inc | 2 | $145 |
| Cathworks, Inc. | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PASCAL$78,819
- COREVALVE EVOLUT R$60,138
- Edwards SAPIEN 3 Transcatheter Heart Valve$44,801
- JenaValve Pericardial TAVR System$38,879
- APOLLOTM$33,087
- EVOQUE$31,766
- Impella$22,100
- Carto 3$14,216
- CoreValve Evolut$13,097
- SYMPLICITY G3$10,500
- (9520) IGT Devices Undivided$9,449
- MitraClip$8,280
- ACUSON SC2000 Diagnostic Ultrasound System$7,151
- AccuCinch$2,463
- VIVID$1,292
- SAPIEN 3 Ultra RESILIA$1,176
- (6554) Peripheral Vascular Undivided$1,063
- Thermocool SF$1,015
- ACUSON Origin Diagnostic Ultrasound System$555
- 3F$444
How this compares
$7,735,698 in reported general payments places this provider in the 95th percentile of 198 cardiovascular disease providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 34 | $509 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Portland
- Ahmad MasriPortland$2.6M
- Scott ChadderdonPortland$1.6M
- Tyler GluckmanPortland$755K
- Stephen HeitnerPortland$434K
- Maros FerencikPortland$239K
- Abigail KhanPortland$149K
- Steven MansoorPortland$130K
- Samuel CamachoPortland$75K
- Jeffrey MarbachPortland$70K
- Peter JesselPortland$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.